Arthur C. Butcher - 12 Feb 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP& Grp Pres, MedSurg & APAC
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
12 Feb 2025
Net transactions value
-$100,482
Form type
4
Filing time
14 Feb 2025, 17:29:50 UTC
Previous filing
13 Feb 2025
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +2,692 +17% $0.000000 18,713 12 Feb 2025 Direct F1
transaction BSX Common Stock Tax liability $100,482 -950 -5.1% $105.77 17,763 12 Feb 2025 Direct
holding BSX Common Stock 13,364 12 Feb 2025 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -2,692 -25% $0.000000 8,078 12 Feb 2025 Common Stock 2,692 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.